LIVE - How to make complex PCI simple
Medtronic Cardiovascular
59 videos
We partner with faculty and with institutions renowned for their expertise in science and education to provide training and education and share best practices.
From this channel, look out for...
We partner with faculty and with institutions renowned for their expertise in science and education to provide training and education and share best practices.
From this channel, look out for panel discussions, live cases, debates and short videos on the recent developments in the treatment of patients with coronary artery disease.
Speakers
Professor Zaman was appointed in 2001 and awarded Honorary Professor of Cardiology by Newcastle University in 2013....
Professor Zaman was appointed in 2001 and awarded Honorary Professor of Cardiology by Newcastle University in 2013. Following graduation at Leeds Medical School, he completed postgraduate training in cardiology at regional centres in Leeds, London and Cardiff. He was a Fulbright Scholar and British Heart Foundation International Fellow in 1998 to study vascular biology at Mount Sinai Medical Center, New York. Professor Zaman is the Clinical Lead for Coronary Intervention and Director of the Cardiac Catheter Laboratories. In 2012 he was appointed Specialty Group Lead for Cardiovascular Research. Prof. Zaman has an interest in clinical research with a particular interest in atherothrombosis in diabetes and clinical trials.
Prof Goran Stankovic is a Professor of Internal Medicine and Cardiology at the Faculty of Medicine, University of...
Prof Goran Stankovic is a Professor of Internal Medicine and Cardiology at the Faculty of Medicine, University of Belgrade, Head of the Department of Cardiology, Clinical Center of Serbia and Chief of Invasive Diagnostics and Interventional Cardiology. Prof. Stankovic was awarded Fellow of the European Society of Cardiology (FESC) in 2003, and Fellow of the American College of Cardiology (FACC) in 2005. He has been a member of European Association for Percutaneous Coronary Interventions (EAPCI) since 2007 and is currently a member of the EAPCI Nominating Committee. He has been one of the founding members and is currently the president of the European Bifurcation Club, and a member of the Asian and Indian Bifurcation Clubs. Professor Stankovic serves on the editorial boards of Journal of the American College of Cardiology, Eurointervention, European Journal of Cardiovascular Medicine, Advances in Interventional Cardiology Journal, and Heart and Blood Vessels – Journal of Cardiology Society of Serbia. For the consecutive years 2005-2014 Professor Stankovic was awarded Elite Reviewer for Journal of American college of Cardiology. In 2009 he received Simon Dack Award for outstanding Scholarship from the American College of Cardiology Foundation.
My cardiology practice and research are focused on the major health issues of coronary artery disease. I believe the...
My cardiology practice and research are focused on the major health issues of coronary artery disease. I believe the optimal outcome is best achieved through the use of appropriate medication long term plus relief of the narrowings or blockages by angioplasty or open heart surgery. To that end my training has been in 3 very large cardiac centres in the UK plus I was fortunate enough to have a training fellowship In Amsterdam. My thesis was in the field of 3-dimensional imaging of the coronary artery lumen, through the University of Birmingham. I was a consultant in a large cardiac surgical centre in Lancashire for 5 years before moving to Norwich in 2009. This was as part of a departmental expansion to deliver 24-hour a day emergency angioplasty to the whole of Norfolk for patients suffering from a heart attack, which successfully improved the results as compared to the use of clot busting injections. I am very fortunate to work in a dynamic and cohesive department who have been supportive of my clinical and research proposals. The cardiac department at the Norfolk and Norwich University Hospital is one of the most experienced centres in the UK in the use of angioplasty with drug delivery without permanent stent implantation and were one of the main contributors to recent important trials in angioplasty including treating difficult branching or dividing blood vessels.